Achira is a New York-based technology company combining artificial intelligence and physics-based simulations to build molecular world models for drug design and the physical sciences.
Subscribe to see Achira’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Achira is an ai/ml company. Xcout tracks 4 named people at Achira, including John Chodera (President / CEO). Xcout recorded 2 job postings from Achira in the last 90 days.
Xcout recorded 2 job postings from Achira in the last 90 days, from a hiring record Xcout has kept since August 2026.
The weekly hiring trend, the roles and locations behind it — see Achira's hiring signals →
A few of Achira's closest competitors — see the full list of competitors and alternatives →
PostEra Inc. is a U.S.-based biotechnology company that develops machine-learning and computational chemistry software for drug discovery and medicinal chemistry. Its platform helps pharmaceutical and biotechnology organizations design, prioritize, and manage experiments for small-molecule therapeutics.
BIO-AI, Inc. develops AI-driven world models to simulate human biology across multiple scales. The company builds programmable virtual cells and a general-purpose cell biology simulator to accelerate research and discovery for medicine, biotechnology, and life sciences.
Azulene Labs builds physics-grounded AI foundation models for chemistry to transform computational chemistry workflows with predictive and precise physics-powered AI.
Apoha utilizes Liquid State intelligence to unlock molecular science data, aiming to design better medicines, food, and materials.
DP Technology is an artificial intelligence startup founded in 2018 that specializes in the "AI for Science" research paradigm. The company develops tools for fundamental research, life sciences, and industrial research and development by applying AI to molecular simulations and scientific problem-solving.
Isomorphic Labs is a drug discovery company that uses predictive and generative artificial intelligence to model biological phenomena and design novel medicines. Building upon the AlphaFold system, the company develops AI-driven tools aimed at accelerating scientific research and treating devastating diseases.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.